Table 2.
Characteristics | Mucoepidermoid carcinoma |
---|---|
Total: N = 19a | |
Genderb | |
Women | 7 |
Men | 11 |
Age (in years)b | |
Range | 40–83 |
Mean | 61 |
Women (mean) | 61 |
Men (mean) | 59 |
Symptom duration (in months)b | |
Range | 0.5–12 |
Mean | 6.2 |
Women (mean) | 7.0 |
Men (mean) | 4.8 |
Symptoms at presentationb,c | |
Mass, facial swelling | 11 |
Obstructive symptoms | 8 |
Pain | 7 |
Drainage, discharge, crusting, bleeding | 6 |
Headaches | 5 |
Nerve changes (paralysis, palsy, paresthesias, numbness, dysphagia, trismus, tingling) | 4 |
Other (proptosis, ptosis, fistula, saddle nose, diplopia) | 5 |
Locationb | |
Mixed (more than one anatomic site) | 10 |
Maxillary sinus only | 4 |
Nasal cavity only | 3 |
Ethmoid sinus only | 2 |
Lateralityb | |
Right | 8 |
Left | 6 |
Bilateral | 1 |
Midline | 1 |
Tumor grade | |
Grade 1 (low-grade) | 5 |
Grade 2 (intermediate-grade) | 5 |
Grade 3 (high-grade) | 9 |
Tumor stage | |
Stage 1 | 4 |
Stage 2 | 4 |
Stage 3 | 4 |
Stage 4 | 7 |
All patients with follow-up (n = 15) (mean years of survival) | |
Follow-up range | 0.5–6 |
Alive, no evidence of disease (n = 7) | 2.7 |
Alive, with disease (n = 4) | 2.5 |
Dead, no evidence of disease (n = 1) | 6.0 |
Dead, with disease (n = 3) | 2.1 |
Alive/Dead, no evidence of disease (n = 8) | 3.1 |
Alive/Dead, with disease (n = 7) | 2.3 |
Patients with recurrence (n = 8) | 3.0 |
Patients without recurrence (n = 6) | 2.8 |
aThis table does not include the series reported in this study
bParameter was not stated in all cases
cPatients may have experienced more than one symptom